RUSSIA WILL JOINTLY PRODUCE SPUTNIK V VACCINE WITH INDIA

Sputnik V has been showing its efficacy over a period of time despite the previous mutations of S-protein," Chief Executive Officer of Russian Direct Investment Fund said.

Sputnik V vaccine has shown 92 per cent efficacy in preventing Covid-19, according to the interim trial results announced by the country's health ministry.

In September 2020, Dr Reddys and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.